Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Lung Cancer
100%
Non Small Cell Lung Cancer
60%
Arm
50%
Randomized Controlled Trial
50%
Patient Monitoring
50%
Intervention Study
50%
Immunotherapy
50%
Circulating Tumor DNA
50%
Cancer Therapy
50%
Overall Survival
42%
Hazard Ratio
30%
Quality of Life
20%
Care Group
12%
Tumor
12%
Exclusion Criterion
12%
Registration Number
12%
Droplet Digital Polymerase Chain Reaction
12%
Computer Assisted Tomography
12%
Next Generation Sequencing
12%
Cancer Staging
12%
Primary Outcome
12%
Medical Oncology
12%
Vinorelbine
10%
Disease Exacerbation
10%
Quality of Life Analysis
10%
Health Care
10%
Small Cell Lung Cancer
10%
Oncology
10%
Subgroup Analysis
10%
Carboplatin
10%
Patient-Reported Outcome
10%
Keyphrases
Remote Symptom Monitoring
50%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
50%
Randomized Controlled Trial
50%
Overall Survival
30%
Hazard Ratio
30%
Lung Cancer
30%
Health-related Quality of Life
30%
Induction Treatment
20%
Control Arm
20%
Symptom Monitoring
20%
Standard of Care
20%
Time Evaluation
12%
Patients with Cancer
10%
Stage III-IV
10%
Quality of Life Analysis
10%
Non-small Cell Lung Cancer Cells
10%
Electronic Survey
10%
Danish Health Care System
10%
Non-small Cell Lung Cancer (NSCLC)
10%
Clinically Significant
10%
P-53
10%
Multicenter Randomized Controlled Trial
10%
Improved Survival
10%
Exploratory Subgroup Analysis
10%
Eastern Cooperative Oncology Group Performance Status (ECOG PS)
10%
Common Symptoms
10%
Carboplatin
10%
Disease Progression
10%
Vinorelbine
10%
Clinical Outcomes
10%
Patient-reported Outcomes
10%
Performance Status 2
10%
